medigraphic.com
ISSN 2007-8560 (Print)
Órgano Oficial de Difusión Científica de la Federación Mexicana de Colegios de Ortopedia y Traumatología, A.C. (FEMECOT)

2023, Number 2

<< Back Next >>

Ortho-tips 2023; 19 (2)

Bleeding and need for transfusion in adults after total knee arthroplasty by subvastus approach who received tranexamic acid

Villalobos-Medélez J, Álvarez-Ojeda JY, Uribe-Saloma CE, Hernández-Molina JR

Language: Spanish
References: 25
Page: 82-87
PDF size: 167.80 Kb.


ABSTRACT

Introduction: total knee arthroplasty (TKA) can cause significant bleeding. Tranexamic acid (TXA) is used to decrease bleeding in various settings. However, there is little information about its use in knee surgery. Objective: to describe the amount of bleeding and the need for blood transfusions in postoperative subjects of TKA by subvastus approach who received ATX. Material and methods: prospective, observational study. Eighty-two adults undergoing TKA by subvastus approach were included. Data were collected such as: initial BH and 24 hours after the procedure, need for transfusion, number of transfused globular packages and surgical time. A single dose of TXA IV was administered to all patients. Results: 82 patients who received ATX were included. The median bleeding was 250 mL. Median preoperative hemoglobin (Hb) was 14.4 g/dL, and postoperative was 12.1 g/dL (delta Hb = -2 g/dL). 3.66% required at least one globular package. Conclusions: this study described the amount of bleeding and the need for transfusion after subvastus TKA using TXA. A historical comparison suggests that TXA decreases postoperative bleeding and perhaps the need for blood transfusion in some patients.


REFERENCES

  1. Espinosa A, Jiménez M, Zorrilla P, López A, Salido JA, Amo M. Influencia del cumplimiento de las expectativas del paciente en los resultados de la artroplastia total de rodilla. Revista española de cirugía ortopédica y Traumatología. 2020; 64 (6): 428-433.

  2. Ortega AM, Barco LR, Rodríguez MEC. Artroplastia total de rodilla. Rev Ortop Traumatol. 2002; 5: 476-484.

  3. Aguilera ZJM, Cruz LF, Encalada DIM, et al. Abordajes quirúrgicos en la artroplastia total de rodilla. Acta Ortop Mex. 2000; 14 (3): 275-278.

  4. Insall JN, Kelly MA. Anatomy. In: Insall JN, Windor RE, Scott WN, Aglietti P (eds). Surgery of the Knee 2 ed. New York: Churchill Livingstone 1993: 1: 1-20.

  5. Hofman AA, Plaster RL, Murdock LE. Subvastus approach for primary total knee arthroplasty. Clin Orthop. 1991; 269: 70-77.

  6. North WT, Mehran N, Davis JJ, Silverton CD, Wier RM, Laker MW. Topical vs intravenous tranexamic acid in primary total hip arthroplasty; a double blind, randomized controlled trial. J Arthroplasty. 2016; 31 (5): 1022.

  7. García-Dobarganes-Barlow FE, Romo-Aguilera IJ, Negrete-Corona J, et al. Effectiveness of tranexamic acid for decreased allogenic blood transfusion in total hip arthroplasty. Acta Ortop Mex. 2020; 34 (1): 6-9.

  8. Churchill JL, Puca KE, Meyer ES, Carleton MC, Truchan SL, Anderson MJ. Comparison of ε-aminocaproic acid and tranexamic acid in reducing postoperative transfusions in total hip arthroplasty. J Arthroplasty. 2016; 31 (12): 2795-2799.e1.

  9. Park KJ, Couch CG, Edwards PK, Siegel ER, Mears SC Barnes CL. Tranexamic acid reduces blood transfusions after total hip and total knee arthroplasty: J Arthroplaty. 2016; 31 (12): 2850-2855.e1.

  10. Alshryda S, Sarda P, Sukeik M, Nargol A, Blenkinsopp J, Mason JM. Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg Br. 2011; 93 (12): 1577-1585.

  11. Wei W, Wei B. Comparison of topical and intravenous tranexamic acid on blood loss and transfusion rates in total hip arthroplasty. J Arthroplasty. 2014; 29 (11): 2113-2116.

  12. Demos HA, Lin ZX, Barfield WR, Wilson SH, Robertson DC, Pellegrini VD Jr. Process improvement project using tranexamic acid is cost-effective in reducing blood loss and transfusions after total hip and total knee arthroplasty. J Arthroplasty. 2017; 32 (8): 2375-2380.

  13. Tuttle JR, Ritterman SA Cassidy DB, Anazon WA, Froehlich JA, Rubin LE. Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty . J Arthroplasty. 2014; 29 (8): 1512-1515.

  14. Luo ZY, Wang HY, Wang D, et al. Oral vs intravenous vs topical tranexamic acid in primary hip arthroplasty: a prospective, randomized, double-blind, controlled study. J Arthroplasty. 2018; 33 (3): 786-793.

  15. Bradley KE, Ryan SP, Penrose CT, et al. Tranexamic acid or epsilon-aminocaproic acid in total joint arthroplasty? A randomized controlled trial. Bone Joint J. 2019; 101-B (9): 1093-1099.

  16. Whiting SR, Duncan CM, Sierra RJ, Smith HM. Tranexamic acid benefits total joint arthroplasty patients regardless of preoperative hemoglobin value. J Arthroplasty. 2015; 30 (12): 2098-2101.

  17. Madsen RV, Nielsen CS, Kallemose T, Husted H, Troeslsen A. Low risk of tromboembolic events after routine administration of tranexamic acid in hip and knee arthroplasty J Arthroplasty. 2017; 32 (4): 1298-1303.

  18. Trial C, Stowers MDJ, Aoina J, Vane A, Poutawera V, Hill AG, et al. Tranexamic acid in knee surgery study-a multicentered, randomized controlled trial. J Arthroplsty. 2017; 32 (11): 3379-3384.

  19. Benjamín JB, Colgan KM. Are routin blood salvage/preservation measures justified in all patients undergoing primary TKA and HTA. J Arthroplasty. 2015; 30 (6): 955-958.

  20. Rajesparan K, Biant LC, Ahmad M, Field RE. The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement. J Bone Joint Surg Br. 2009; 91 (6): 776-783.

  21. Fillingham YA, Ramkumar DB, Jevsevar DS, Yates AJ, Bini SA, Clarke HD. Tranexamic acid use in total joint arthroplasty: the clinical practice guidelines endorsed by the American Association of Hip and Knee Surgeons, American Society of Regional Anesthesia and Pain Medicine, American Academy of Orthopaedic Surgeons, Hip Society, and Knee Society. J Arthroplasty. 2018; 33 (10): 3065-3069.

  22. Almeida MDC, Albuquerque RPE, Palhares GM, Almeida JPC, Barretto JM, Cavanellas N. Evaluation of the use of tranexamic acid in total knee arthroplasty. Rev Bras Ortop. 2018; 53 (6): 761-767.

  23. Sadigursky D, Andion D, Boureau P, Ferreira MC, Carneiro RJF, Colavolpe PO. Effect of tranexamic acid on bleeding control in total knee arthroplasty. Acta Ortop Bras. 2016; 24 (3): 131-136.

  24. Sanz-Reig J, Ruiz BP, Martínez JF, López JM. Single intravenous tranexamic acid dose to reduce blood loss in primary total knee replacement. Rev Esp Cir Ortop Traumatol. 2016; 60 (2): 106-112.

  25. Seol YJ, Seon JK, Lee SH, et al. Effect of tranexamic acid on blood loss and blood transfusion reduction after total knee arthroplasty. Knee Surg Relat Res. 2016; 28 (3): 188-193.



EVIDENCE LEVEL

III




2020     |     www.medigraphic.com